Ramaglia10 found that EZH2 was expressed with a different degree in 60% of 17 patients with Ewing sarcoma or RMS and it was significantly higher in patients presenting lymph node and/or distant metastases. This evidence concerns the gene EZH2 and Ewing sarcoma.